首页> 外文期刊>Nordic and Baltic Journal of Information and Communications Technologies >Pharma Industrial Internet: A Reference Model Based on 5G Public Private Partnership Infrastructure, Industrial Internet Consortium Reference Architecture and Pharma Industry Standards
【24h】

Pharma Industrial Internet: A Reference Model Based on 5G Public Private Partnership Infrastructure, Industrial Internet Consortium Reference Architecture and Pharma Industry Standards

机译:制药工业互联网:基于5G公私合营基础设施,工业互联网联盟参考架构和制药行业标准的参考模型

获取原文
获取外文期刊封面目录资料

摘要

Pharma industry is undergoing a major transformation called ‘The new pharma reality’ caused by the changes in global pharmaceutical business ecosystem and strive for the improved regulatory compliance and competitiveness. The current manufacturing and enterprise IT systems have not been satisfactorily able to deliver on the new requirements and this is leading pharma companies investigating the benefits of the current trends of digitalization, IoT and enhanced networking capabilities. This paper introduces the concept of Pharma Industrial Internet, a reference model for applying the 5G PPP Infrastructure, Industrial Internet Consortium Reference Architecture and key pharma industry manufacturing standards for specifying, modeling and building pharma industry specific industrial internet solutions. By applying the reference model, pharmaceutical manufacturers will be able to improve their competitiveness while meeting the global regulatory and manufacturing quality requirements. The paper provides a holistic view on the digitalization transformation taking place in the pharmaceutical industry, the technical enablers driving the transformation and the new service infrastructures and value-add enterprise services helping the pharma companies to compete in the new pharma reality.
机译:全球制药业务生态系统的变化引起了制药行业的重大变革,称为“新制药现实”,并致力于提高法规遵从性和竞争力。当前的制造和企业IT系统无法令人满意地满足新要求,这使领先的制药公司正在研究当前数字化,物联网和增强的联网功能趋势的好处。本文介绍了制药工业互联网的概念,用于应用5G PPP基础架构的参考模型,工业互联网联盟参考架构以及用于指定,建模和构建特定于制药行业的工业互联网解决方案的关键制药行业制造标准。通过使用参考模型,药品制造商将能够提高其竞争力,同时满足全球法规和制造质量要求。本文提供了有关制药行业发生的数字化转型,推动转型的技术推动力以及新的服务基础架构和增值企业服务的整体视图,这些服务有助于制药公司在新的制药现实中竞争。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号